Empagliflozin 10 MG
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of East Anglia
Overview
Empagliflozin 10 MG is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Empagliflozin 10 MG clinical trials
Explore related
Medical disclaimer. This page summarizes research about Empagliflozin 10 MG for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.